Sponsored Research
Michael D. Gunn of Cardiology has received a sub-award (U01-ES015673) through the University of Louisville for a project entitled "Novel therapies for chlorine-induced lung injury (U01 ES015673 sub award)." Total funding will be $164,926.
Robert J. Mentz of Cardiology has received an award through Saint Luke's Hospital for a project entitled "Define-HF." Total funding will be $176,040.
Matthew T. Roe of Cardiology has received an award from the American Heart Association for a project entitled "Mission Lifeline Jan 2016 - June 2016." Total funding will be $300,602.
Matthew T. Roe of Cardiology has received an award from the American College of Cardiology Foundation for a project entitled "NCDR-ACTION." Total funding will be $398,157.
Deepak Voora of Cardiology has received an award from the National Heart Centre Singapore for a project entitled "Molecular Signatures of the Response to Aspirin in a Chinese Population." Total funding will be $82,599.
Rodger A. Liddle of Gastroenterology has received an award (1R01-DK109368-01) from the National Institutes of Health for a project entitled "The role of gut endocrine cells in Parkinson's Disease." Total funding will be $1,430,970.
Eugene Z. Oddone of General Internal Medicine has received a sub-award (AD-1408 19519) through the University of North Carolina - Chapel Hill for a project entitled "Pain Coping Skills Training for African Americans with Osteoarthritis." Total funding will be $123,306.
Nelson J. Chao of Hematological Malignancies and Cellular Therapy has received an award from the National Marrow Donor Program for a project entitled "Radiation Injury Treatment Network." Total funding will be $8,000.
Jun Chen of Hematological Malignancies and Cellular Therapy has received a sub-award through the Wake Forest University School of Medicine for a project entitled "Immunological Injury and Recovery." Total funding will be $1,113,958.
Stefanie Sarantopoulos of Hematological Malignancies and Cellular Therapy has received a sub-award (5 R01-CA118953-08) through the Fred Hutchinson Cancer Research Center for a project entitled "Improving Outcomes Assessment in cGVHD." Total funding will be $18,745.
John A. Bartlett of Infectious Diseases has received an award from Wake County Human Services for a project entitled "HIV Adult ID Services, Year 7." Total funding will be $151,925.
Mehri McKellar of Infectious Diseases has received an award from Wake County Human Services for a project entitled "Region 6 Network of Care." Total funding will be $56,218.
Jason E. Stout of Infectious Diseases has received a sub-award (U52-PS004698) through the NC Department of Health and Human Services for a project entitled "Epidemiology/General Communicable Disease Control." Total funding will be $85,933.
Allison E. Ashley-Koch of Nephrology has received a sub-award (R01-NS073872) through Columbia University for a project entitled "Identification of Susceptibility Genes for Essential Tremor." Total funding will be $98,381.
Steven D. Crowley of Nephrology has received an award (1R01-HL128355-01A1) from the National Institutes of Health for a project entitled "Role of Dendritic Cell-mediated T Cell Activation in Salt-sensitive Hypertension." Total funding will be $1,806,384.
Christopher Cox of Pulmonary, Allergy, and Critical Care Medicine has received an award (R18-FD005292) from the Food and Drug Administration for a project entitled "HABP/VABP."
Alice L. Gray of Pulmonary, Allergy, and Critical Care Medicine has received an award from the Cystic Fibrosis Foundation for a project entitled "CFF."
Loretta Que of Pulmonary, Allergy, and Critical Care Medicine has received a sub-award (R01-HL125602) through the University of Arizona for a project entitled "Surfactant Protein-A regulation of eosinophil apoptosis in asthma." Total funding will be $93,472.
Megan E. Clowse of Rheumatology and Immunology has received an award from the National Institutes of Health for a project entitled "International Conference on Reproduction, Pregnancy, and Rheumatic Disease." Total funding will be $15,000.
Industry-sponsored Clinical Trials
Terry A. Fortin of Cardiology has received an award from Actelion Pharmaceuticals Ltd. for a project entitled "Multicenter, open-label, single-group study to assess the tolerability and the safety of the TRANSITion from inhaled treprostinil to oral selexipag in adult patients with pulmonary arterial hypertension." Total funding will be $105,103.
William S. Jones of Cardiology has received an award from Bayer Healthcare Pharmaceuticals Inc for a project entitled "VOYAGER." Total funding will be $327,990.
Renato D. Lopes of Cardiology has received an award from Eli Lilly and Company for a project entitled "A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus (AWARD-10: Assessment of Weekly AdministR." Total funding will be $180,979.
Renato D. Lopes of Cardiology has received an award from Amgen, Inc. for a project entitled "AMG423 2012227." Total funding will be $215,418.
Robert J. Mentz of Cardiology has received an award from Amgen, Inc. for a project entitled "PRIME HF." Total funding will be $8,661,273.
Manesh R. Patel of Cardiology has received an award from Cardiovascular Systems Inc. for a project entitled "CSI Educational Program Agreement VI." Total funding will be $14,605.
Manesh R. Patel of Cardiology has received an award from Bayer Inc. for a project entitled "ROCKET AF Manuscripts." Total funding will be $422,364.
Matthew T. Roe of Cardiology has received an award from Ferring Pharmaceuticals for a project entitled "Phase II Study (LOI)." Total funding will be $2,159,536.
Pierluigi Tricoci of Cardiology has received an award from Sanofi US for a project entitled "Protocol EFC14074." Total funding will be $166,090.
Manal F. Abdelmalek of Gastroenterology has received an award from Intercept Pharmaceuticals, Inc for a project entitled "Intercept 747-209 A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects with Nonalcoholic Steatohepatitis." Total funding will be $293,812.
Cristina Gasparetto of Hematological Malignancies and Cellular Therapy has received an award from Stemline Therapeutics, Inc for a project entitled "Phase 1/2 Open label study of SL-401 with Pom/Dex in R/R MM." Total funding will be $231,975.
Stefanie Sarantopoulos of Hematological Malignancies and Cellular Therapy has received an award from Gilead Sciences, Inc. for a project entitled "A Phase II of Entospletinib, a SYK Inhibitor, First line cGVHD patients." Total funding will be $138,408.
Gowthami Arepally of Hematology has received an award from Siemens Healthcare Diagnostics for a project entitled "Clinical Study Protocol for External Performance Evaluation of INNOVANCE Heparin on BCS XPїMethod Comparison." Total funding will be $59,912.
Marilyn J. Telen of Hematology has received an award from Pfizer, Inc. for a project entitled "An Open-Label Extension Study To Evaluate The Safety Of Rivipansel (Gmi-1070) In The Treatment Of One Or More Vasoocclusive Crises In Hospitalized Subjects With Sickle Cell Disease." Total funding will be $539,059.
Mehri McKellar of Infectious Diseases has received an award from Gilead Sciences, Inc. for a project entitled "Gilead - GS-380-1878." Total funding will be $74,902.
Mehri McKellar of Infectious Diseases has received an award from Gilead Sciences, Inc. for a project entitled "Gilead - GS - US - 380-1844." Total funding will be $128,596.
Mehri McKellar of Infectious Diseases has received an award from Gilead Sciences, Inc. for a project entitled ""A Phase 3b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Subjects on Chronic Hemodialysis [GS-US-292-1825]." Total funding will be $43,468.
Kimberly L. Blackwell of Medical Oncology has received an award from Merck Sharp & Dohme for a project entitled "A Randomized Open-Label Phase III Study of Single Agent Pembrolizumab versus Single Agent Chemotherapy per Physician's Choice for Metastatic Triple Negative Breast Cancer (mTNBC) (KEYNOTE-119)." Total funding will be $2,088,211.
Jeffrey M. Clarke of Medical Oncology has received an award from Adaptimmune Limited for a project entitled "A screening protocol to determine tumor antigen expression and HLA sub-type for eligibility determination for clinical trials evaluating the safety and efficacy of Autologous T Cell expressing enhance." Total funding will be $20,904.
Michaela A. Dinan of Medical Oncology has received an award from Genzyme Corporation for a project entitled "Thyrogen Utilization Patterns in the Treatment of Thyroid Cancer." Total funding will be $231,720.
Stephanie Gaillard of Medical Oncology has received an award from Genentech, Inc. for a project entitled "An Open label phase II study evaluatint Traztuzumab/Pertuzumab, Erlotinib, Vemurafenib, and Vismodegib in patients who have advanced cancer." Total funding will be $76,742.
Brent A. Hanks of Medical Oncology has received an award from MedPacto, Inc for a project entitled "Investigation of TEW-7197 in Combination with Immune Checkpoint Inhibition in the BRAFV600E-PTEN-/- Melanoma Model." Total funding will be $38,908.
Brent A. Hanks of Medical Oncology has received an award from OncoMed Pharmaceuticals for a project entitled "Investigation of the FZD8-Fc Wnt Ligand Antagonist and the Fzd Receptor Monoclonal Antibody in Combination with Immune Checkpoint Blockade in Pre-Clinical Melanoma, Non-Small Cell Lung Cancer, and Col." Total funding will be $315,427.
Neal E. Ready of Medical Oncology has received an award from Stem CentRx, Inc for a project entitled "A Phase 2 Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-line Treatment of Patients with Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer (TRINITY)." Total funding will be $127,171.
April K. Salama of Medical Oncology has received an award from the Bristol-Myers Squibb Company for a project entitled "A US Multi-Site Observational Study in Patients with Unresectable and Metastatic Melanoma: The OPTIMIzE Study." Total funding will be $229,596.
April K. Salama of Medical Oncology has received an award from Immunocore Limited for a project entitled "A Phase Ib/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 in Combination with Durvalumab (MEDI4736) or Tremelimumab or the Combination of Durvalumab and Tremelimumab Compared to IMCgp100 Alone in Patients with Advanced Melan." Total funding will be $595,638.
John H. Strickler of Medical Oncology has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 3 Randomized double blined placebo controlled study to evaluate the efficacy and safety of GS-5745 conbimed with mFOLFAX6 as first line treatment in patients with advanced gastric or gastroeso." Total funding will be $175,772.
Hope E. Uronis of Medical Oncology has received an award from MacroGenics, Inc for a project entitled "A Phase 1b/2 open label dose escalation study of Margetuximab incombination with Pembrolizumab in patients with relapsed refrectory advanced HER2 + Gastroesophageal junction or gastric cancer." Total funding will be $180,487.
Gordana Vlahovic of Medical Oncology has received a award through Annias Immunotherapeutics, Inc. for a project entitled "Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma." Total funding will be $436,292.
Kevin A. Schulman of Other Medicine has received an award from Humacyte, Inc. for a project entitled "Humacyte Study." Total funding will be $284,222.
Njira L. Lugogo of Pulmonary, Allergy, and Critical Care Medicine has received an award from Grifols USA, LLC for a project entitled "COPD Interactive Training Program." Total funding will be $24,000.
E. William St Clair of Rheumatology and Immunology has received an award from Lilly USA, LLC for a project entitled "A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3200327 in Subjects with Active Sjцgrenїs Syndrome." Total funding will be $195,206.